Ahmedabad, 2nd September 2024: HCG Aastha Cancer Centre Ahmedabad successfully performs Gujarat’s first robotic neck dissection combined with free flap reconstruction to treat patients suffering with oral cancers. This groundbreaking approach minimizes visible neck scars, offers exceptional outcomes, particularly for younger patients, and sets a new standard in advanced medical care. Led by Dr. Nitin Sharma, a leading Robotic Head & Neck and Endoscopic Skull Base Surgeon, and his team of highly skilled specialists, this milestone highlights HCG’s commitment to advancing medical innovation and enhancing patient care.
Mr. Jatin (name changed), a 36-year-old from Ahmedabad, faced a challenging and painful ordeal when he was diagnosed with oral cancer (mouth cancer). He had been struggling with persistent, non-healing ulcers and found it increasingly difficult to swallow, which led him to seek medical help. The discomfort and disruption to his daily life were immense, and he hoped for a solution that could bring relief and restore his quality of life.
Anita (name changed) who is a nursing student. When her father was diagnosed with cancer of the right lower jaw, was determined to ensure her father’s confidence and appearance were preserved post-surgery. Similarly, Deepa Ben (name changed), a 46-year-old who previously underwent surgery for oral cancer, sought to avoid facial scarring during her second cancer treatment.
Both patients faced the emotional and physical challenges that come with a cancer diagnosis, highlighting the crucial need for timely medical intervention and compassionate care. At HCG Aastha Cancer Centre, Ahmedabad, they underwent robotic neck dissections combined with free flap reconstruction—a surgical procedure that precisely removes cancerous tissue and replaces it with tissue from another part of the body to reconstruct the affected area, resulting in minimal scarring. This advanced treatment provided them with not only cutting-edge care but also a nurturing environment that addressed their concerns and guided them through their challenging paths to recovery.
Dr. Nitin Sharma, Robotic Head & Neck and Endoscopic Skull Base Surgeon, HCG Aastha Cancer Centre, Ahmedabad, stated, “Oral cancer is no longer confined to the elderly; we now see many young, socially and professionally active patients who expect to look the same after surgery. Cosmetic oncology, as emphasized by Dr. Dhanushya Gohil, is an emerging field focused on addressing both aesthetic and functional aspects post-surgery, allowing patients to return to their previous quality of life. The integration of robotics, free flaps, and onco-dentistry has revolutionized this field, offering significant benefits with minimal additional cost.”
Dr. Kaustubh Patel, alongside Dr. Dushyant Mandlik, highlighted, “The department of Head & Neck Surgery at HCG Aastha Cancer Centre, Ahmedabad, is one of the most advanced in West India, performing over 1,800 surgeries annually. These include cutting-edge robotic surgeries, free flap procedures, and endoscopic skull base surgeries. We are proud to be the first in Gujarat to successfully perform this groundbreaking surgery, highlighting our commitment to medical innovation.”
Mr. Jatin expressed his gratitude, saying, “Initially, I was very apprehensive about the surgery for my mouth cancer due to concerns about potential scarring and the impact on my voice. However, Dr. Nitin Sharma and his team took the time to explain the entire procedure clearly, easing my fears. Their reassurance and extensive experience in handling such cases, including successful surgeries for similar cancers, gave me confidence. Today, I’m relieved to be free of pain and cancer, without significant scarring, which has allowed me to return to a normal voice & life with my family. I’m deeply grateful to HCG and their team of skilled and compassionate doctors.”
HCG Aastha Cancer Centre‘s successful execution of the free flap surgery marks a significant advancement in medical science. This achievement not only highlights the centre’s commitment to pioneering advanced treatments but also reinforces its standing as a leader in corporate healthcare excellence.